Is AN2 Therapeutics Inc (ANTX) Stock a Bad Value Tuesday?

AN2 Therapeutics Inc (ANTX) is near the bottom in its sector according to InvestorsObserver. ANTX gets an overall rating of 4. That means it scores higher than 4% of stocks. AN2 Therapeutics Inc gets a 27 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

ANTX has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on ANTX!

See Full ANTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 4 means the stock is more attractive than 4 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With AN2 Therapeutics Inc Stock Today?

AN2 Therapeutics Inc (ANTX) stock has risen 3.24% while the S&P 500 has fallen -0.82% as of 11:22 AM on Tuesday, Mar 5. ANTX has risen $0.09 from the previous closing price of $2.78 on volume of 73,398 shares. Over the past year the S&P 500 is up 25.71% while ANTX has fallen -70.01%. ANTX lost -$2.86 per share the over the last 12 months. Click Here to get the full Stock Report for AN2 Therapeutics Inc stock.